Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)
- Author
- B BIESMA, C MANEGOLD, HJM SMIT, L WILLEMS, C LEGRAND, A PASSIOUKOV, Jan Van Meerbeeck (UGent) and G GIACCONE
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-360607
- MLA
- BIESMA, B., et al. “Docetaxel and Cisplatin as Induction Chemotherapy in Patients with Pathologically-Proven Stage IIIA N2 Non-Small Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer (EORTC 08984).” EUROPEAN JOURNAL OF CANCER, vol. 42, no. 10, ELSEVIER SCI LTD, 2006, pp. 1399–406.
- APA
- BIESMA, B., MANEGOLD, C., SMIT, H., WILLEMS, L., LEGRAND, C., PASSIOUKOV, A., … GIACCONE, G. (2006). Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984). EUROPEAN JOURNAL OF CANCER, 42(10), 1399–1406.
- Chicago author-date
- BIESMA, B, C MANEGOLD, HJM SMIT, L WILLEMS, C LEGRAND, A PASSIOUKOV, Jan Van Meerbeeck, and G GIACCONE. 2006. “Docetaxel and Cisplatin as Induction Chemotherapy in Patients with Pathologically-Proven Stage IIIA N2 Non-Small Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer (EORTC 08984).” EUROPEAN JOURNAL OF CANCER 42 (10): 1399–1406.
- Chicago author-date (all authors)
- BIESMA, B, C MANEGOLD, HJM SMIT, L WILLEMS, C LEGRAND, A PASSIOUKOV, Jan Van Meerbeeck, and G GIACCONE. 2006. “Docetaxel and Cisplatin as Induction Chemotherapy in Patients with Pathologically-Proven Stage IIIA N2 Non-Small Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer (EORTC 08984).” EUROPEAN JOURNAL OF CANCER 42 (10): 1399–1406.
- Vancouver
- 1.BIESMA B, MANEGOLD C, SMIT H, WILLEMS L, LEGRAND C, PASSIOUKOV A, et al. Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984). EUROPEAN JOURNAL OF CANCER. 2006;42(10):1399–406.
- IEEE
- [1]B. BIESMA et al., “Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984),” EUROPEAN JOURNAL OF CANCER, vol. 42, no. 10, pp. 1399–1406, 2006.
@article{360607, author = {{BIESMA, B and MANEGOLD, C and SMIT, HJM and WILLEMS, L and LEGRAND, C and PASSIOUKOV, A and Van Meerbeeck, Jan and GIACCONE, G}}, issn = {{0959-8049}}, journal = {{EUROPEAN JOURNAL OF CANCER}}, language = {{eng}}, number = {{10}}, pages = {{1399--1406}}, publisher = {{ELSEVIER SCI LTD}}, title = {{Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)}}, volume = {{42}}, year = {{2006}}, }